Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.3 appears on the page, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These changes are administrative and do not affect trial data or user actions.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedRevision v3.3.2 was added and Revision v3.2.0 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding/operating-status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check59 days agoChange DetectedVersion 13 was posted on 2025-06-06 with an update to the Study Status.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded a government funding/status notice and updated version to v3.2.0; removed old v3.1.0 tag.SummaryDifference12%

- Check95 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.